July 6, 2020
Late-stage COVID-19 vaccine trials to start this summer
Editor's Note
The National Institute of Allergy and Infectious Diseases director Anthony Fauci says COVID-19 vaccine candidates will start moving into late-stage clinical trials by the end of July, continuing through the summer and into fall, the July 2 Reuters reports.
The director of the National Institutes of Health, Dr Francis Collins, also said the administration’s vaccine-acceleration program could generate a safe, effective vaccine by year-end.
Free Daily News
- Commentary: Cyberattacks threaten financial survival of surgical practices
- Tariffs strain supply chains, split medical manufacturing community
- Study: Systemic gender bias embedded in surgical practice
- Literature review: Endoscope disinfection failures highlight need for stronger sterilization practices
- Study: GLP-1 drugs heighten risk of gastric residue but not perioperative pulmonary aspiration
- OAS CAHPS compliance soars to 96% among ASCs, vendor satisfaction also improves
- Knee surgical robot market set to surge, projected to reach $5.9B by 2032
- Health system mega-mergers fall short amid cost, quality concerns
- Health systems boost security spending as workplace violence escalates
- Strengthening healthcare cyber defenses challenged by third-party, asset-related risks
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement